AIDX compared with ULS: revenue, margins and what each company keeps, and the suppliers and customers both name

AIDX20/20 Biolabs, Inc.

Mkt capRevenueRevenue

ULSUL Solutions Inc.

Mkt capRevenueRevenue

Compare

AIDX20/20 Biolabs, Inc.

ULSUL Solutions Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AIDX1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−6.21%—

ULS2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.0%▲+7.00%×0.78

Q2 FY26—▼−13.96%—

= impliedAIDX realized, solidULS realized, hatchedOne scale, both sides: full bar = 14%× = |realized| ÷ impliedSource: market data

AIDX20/20 Biolabs, Inc.

0.24▲+28.73%· post 0.20

Mkt cap$2.1MRevenue$730,571Q2 FY26Revenue—

ULSUL Solutions Inc.

78.72▲+3.37%· post 78.72

ClosedNov 6 '26

Mkt cap$15.9BRevenue$823MQ3 FY26Revenue$3.1BFY25

Compare

ClosedNov 6 '26

AIDX20/20 Biolabs, Inc.

ULSUL Solutions Inc.

0.24▲+28.73%post 0.20

Price

78.72▲+3.37%post 78.72

$2.1M

Mkt cap

$15.9B

Q2 FY26$730,571

Revenue

$823MQ3 FY26

—

Revenue

$3.1BFY25

AIDX0.24▲+28.73%vsULS78.72▲+3.37%ClosedNov 6 '26